A Systematic Review: Fecal Bacterial Profile in Patients with Irritable Bowel Syndrome Analyzed with the GA-Map Dysbiosis Test Based on the 16S rRNA Gene of Bacterial Species or Groups

References

• Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV. Gastroenterology. 2016;150(6):1262–1279.e2. doi:10.1053/j.gastro.2016.02.032
   Web of Science ®Google Scholar
• Sperber AD, Bangdiwala SI, Drossman DA, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome foundation global study. Gastroenterology. 2021;160(1):99–114 e113. doi:10.1053/j.gastro.2020.04.014
   PubMed Web of Science ®Google Scholar
• Mearin F, Lacy BE, Chang L, et al. Bowel Disorders. Gastroenterology. 2016:S0016–5085.
   PubMedGoogle Scholar
• Enck P, Aziz Q, Barbara G, et al. Irritable bowel syndrome. Nat Rev Dis Primers. 2016;2:16014. doi:10.1038/nrdp.2016.14
   PubMed Web of Science ®Google Scholar
• Drossman DA, Morris CB, Schneck S, et al. International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit. J Clin Gastroenterol. 2009;43(6):541–550. doi:10.1097/MCG.0b013e318189a7f9
   PubMed Web of Science ®Google Scholar
• Corsetti M, Whorwell P. The global impact of IBS: time to think about IBS-specific models of care? Therap Adv Gastroenterol. 2017;10(9):727–736. doi:10.1177/1756283X17718677
   PubMed Web of Science ®Google Scholar
• Chong PP, Chin VK, Looi CY, Wong WF, Madhavan P, Yong VC. The microbiome and irritable bowel syndrome - A review on the pathophysiology, current research and future therapy. Front Microbiol. 2019;10:1136. doi:10.3389/fmicb.2019.01136
   PubMed Web of Science ®Google Scholar
• Piche T, Barbara G, Aubert P, et al. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut. 2009;58(2):196–201. doi:10.1136/gut.2007.140806
   PubMed Web of Science ®Google Scholar
• Barbara G, Cremon C, Carini G, et al. The immune system in irritable bowel syndrome. J Neurogastroenterol Motil. 2011;17(4):349–359. doi:10.5056/jnm.2011.17.4.349
   PubMed Web of Science ®Google Scholar
• Casen C, Vebo HC, Sekelja M, et al. Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD. Aliment Pharmacol Ther. 2015;42(1):71–83. doi:10.1111/apt.13236
   PubMed Web of Science ®Google Scholar
• Ahluwalia B, Iribarren C, Magnusson MK, et al. A distinct faecal microbiota and metabolite profile linked to bowel habits in patients with irritable bowel syndrome. Cells. 2021;10(6):1459. doi:10.3390/cells10061459
   PubMed Web of Science ®Google Scholar
• Vasapolli R, Schulz C, Schweden M, et al. Gut microbiota profiles and the role of anti-CdtB and anti-vinculin antibodies in patients with functional gastrointestinal disorders (FGID). Eur J Clin Invest. 2021;51(12):e13666. doi:10.1111/eci.13666
   PubMed Web of Science ®Google Scholar
• Iribarren C, Nordlander S, Sundin J, et al. Fecal luminal factors from patients with irritable bowel syndrome induce distinct gene expression of colonoids. Neurogastroenterol Motil. 2022;34(10):e14390. doi:10.1111/nmo.14390
   PubMed Web of Science ®Google Scholar
• Mazzawi T, Lied GA, Sangnes DA, et al. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation. PLoS One. 2018;13(11):e0194904. doi:10.1371/journal.pone.0194904
   PubMed Web of Science ®Google Scholar
• Pittayanon R, Lau JT, Yuan Y, et al. Gut microbiota in patients with irritable bowel syndrome-A systematic review. Gastroenterology. 2019;157(1):97–108. doi:10.1053/j.gastro.2019.03.049
   PubMed Web of Science ®Google Scholar
• Gaulke CA, Sharpton TJ. The influence of ethnicity and geography on human gut microbiome composition. Nature Med. 2018;24(10):1495–1496. doi:10.1038/s41591-018-0210-8
   PubMed Web of Science ®Google Scholar
• Duan R, Zhu S, Wang B, Duan L. Alterations of gut microbiota in patients with irritable bowel syndrome based on 16S rRNA-targeted sequencing: a systematic review. Clin Transl Gastroenterol. 2019;10(2):e00012. doi:10.14309/ctg.0000000000000012
   PubMedGoogle Scholar
• Liu HN, Wu H, Chen YZ, Chen YJ, Shen XZ, Liu TT. Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: a systematic review and meta-analysis. Dig Liver Dis. 2017;49(4):331–337. doi:10.1016/j.dld.2017.01.142
   PubMedGoogle Scholar
• Gargari G, Taverniti V, Gardana C, et al. Fecal clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome. Environ Microbiol. 2018;20(9):3201–3213. doi:10.1111/1462-2920.14271
   PubMed Web of Science ®Google Scholar
• Rajilic-Stojanovic M, Biagi E, Heilig HG, et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology. 2011;141(5):1792–1801. doi:10.1053/j.gastro.2011.07.043
   PubMed Web of Science ®Google Scholar
• Zhao L, Yang W, Chen Y, et al. A Clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome. J Clin Invest. 2020;130(1):438–450. doi:10.1172/JCI130976
   PubMed Web of Science ®Google Scholar
• Mawe GM, Hoffman JM. Serotonin signalling in the gut--functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol. 2013;10(8):473–486.
   PubMed Web of Science ®Google Scholar
• Yano JM, Yu K, Donaldson GP, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;161(2):264–276. doi:10.1016/j.cell.2015.02.047
   PubMed Web of Science ®Google Scholar
• Borriello SP. Clostridial disease of the gut. Clinl Infect Dis. 1995;20(Supplement_2):S242–250. doi:10.1093/clinids/20.Supplement_2.S242
   PubMedGoogle Scholar
• Wadhwa A, Al Nahhas MF, Dierkhising RA, et al. High risk of post-infectious irritable bowel syndrome in patients with Clostridium difficile infection. Aliment Pharmacol Ther. 2016;44(6):576–582. doi:10.1111/apt.13737
   PubMed Web of Science ®Google Scholar
• Guo P, Zhang K, Ma X, He P. Clostridium species as probiotics: potentials and challenges. J Anim Sci Biotechnol. 2020;11(1):24. doi:10.1186/s40104-019-0402-1
   PubMed Web of Science ®Google Scholar
• Tottey W, Feria-Gervasio D, Gaci N, et al. Colonic transit time is a driven force of the gut microbiota composition and metabolism: in vitro evidence. J Neurogastroenterol Motil. 2017;23(1):124–134.
   PubMed Web of Science ®Google Scholar
• Fukumoto S, Tatewaki M, Yamada T, et al. Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats. Am J Physiol Regul Integr Comp Physiol. 2003;284(5):1269–1276. doi:10.1152/ajpregu.00442.2002
   PubMed Web of Science ®Google Scholar
• Zhai L, Huang C, Ning Z, et al. Ruminococcus gnavus plays a pathogenic role in diarrhea-predominant irritable bowel syndrome by increasing serotonin biosynthesis. Cell Host Microbe. 2023;31(1):33–44 e35. doi:10.1016/j.chom.2022.11.006
   PubMed Web of Science ®Google Scholar
• Kendig DM, Grider JR. Serotonin and colonic motility. Neurogastroenterol Motil. 2015;27(7):899–905. doi:10.1111/nmo.12617
   PubMed Web of Science ®Google Scholar
• Bennet SM, Ohman L, Simren M. Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver. 2015;9(3):318–331.
   PubMed Web of Science ®Google Scholar
• Jalanka-Tuovinen J, Salojarvi J, Salonen A, et al. Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome. Gut. 2014;63(11):1737–1745. doi:10.1136/gutjnl-2013-305994
   PubMed Web of Science ®Google Scholar
• Carroll IM, Ringel-Kulka T, Siddle JP, Ringel Y. Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil. 2012;24(6):521–530, e248. doi:10.1111/j.1365-2982.2012.01891.x
   PubMed Web of Science ®Google Scholar
• Krogius-Kurikka L, Lyra A, Malinen E, et al. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol. 2009;9(1):95. doi:10.1186/1471-230X-9-95
   PubMedGoogle Scholar
• Altomare A, Di Rosa C, Imperia E, Emerenziani S, Cicala M, Guarino MPL. Diarrhea predominant-irritable bowel syndrome (IBS-D): effects of different nutritional patterns on intestinal dysbiosis and symptoms. Nutrients. 2021;13(5):1506. doi:10.3390/nu13051506
   PubMed Web of Science ®Google Scholar
• Binda C, Lopetuso LR, Rizzatti G, Gibiino G, Cennamo V, Gasbarrini A. Actinobacteria: a relevant minority for the maintenance of gut homeostasis. Dig Liver Dis. 2018;50(5):421–428. doi:10.1016/j.dld.2018.02.012
   PubMedGoogle Scholar
• O’Callaghan A, van Sinderen D. Bifidobacteria and their role as members of the human gut microbiota. Front Microbiol. 2016;7:925. doi:10.3389/fmicb.2016.00925
   PubMed Web of Science ®Google Scholar
• Picard C, Fioramonti J, Francois A, Robinson T, Neant F, Matuchansky C. Review article: bifidobacteria as probiotic agents -- physiological effects and clinical benefits. Aliment Pharmacol Ther. 2005;22(6):495–512. doi:10.1111/j.1365-2036.2005.02615.x
   PubMed Web of Science ®Google Scholar
• Marasco G, Cremon C, Barbaro MR, Stanghellini V, Barbara G. Gut microbiota signatures and modulation in irritable bowel syndrome. Microbiome Res Rep. 2022. doi:10.20517/mrr.2021.12
   PubMedGoogle Scholar
• Wang L, Alammar N, Singh R, et al. Gut microbial dysbiosis in the irritable bowel syndrome: a systematic review and meta-analysis of case-control studies. J Acad Nutr Diet. 2020;120(4):565–586. doi:10.1016/j.jand.2019.05.015
   PubMed Web of Science ®Google Scholar
• Fukui H, Nishida A, Matsuda S, et al. Usefulness of machine learning-based gut microbiome analysis for identifying patients with irritable bowels syndrome. J Clin Med. 2020;9(8):2403. doi:10.3390/jcm9082403
   PubMed Web of Science ®Google Scholar
• Tap J, Derrien M, Tornblom H, et al. Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome. Gastroenterology. 2017;152(1):111–123 e118. doi:10.1053/j.gastro.2016.09.049
   PubMed Web of Science ®Google Scholar
• Shankar V, Reo NV, Paliy O. Simultaneous fecal microbial and metabolite profiling enables accurate classification of pediatric irritable bowel syndrome. Microbiome. 2015;3(1):73. doi:10.1186/s40168-015-0139-9
   PubMedGoogle Scholar
• Beam A, Clinger E, Hao L. Effect of diet and dietary components on the composition of the gut microbiota. Nutrients. 2021;13(8):2795. doi:10.3390/nu13082795
   PubMed Web of Science ®Google Scholar
• Lacy BE, Patel NK. Rome criteria and a diagnostic approach to irritable bowel syndrome. J Clin Med. 2017;6(11):99. doi:10.3390/jcm6110099
   PubMed Web of Science ®Google Scholar
• Kim YS, Kim N. Sex-gender differences in irritable bowel syndrome. J Neurogastroenterol Motil. 2018;24(4):544–558. doi:10.5056/jnm18082
   PubMed Web of Science ®Google Scholar